Cem Haymana

762 total citations
45 papers, 433 citations indexed

About

Cem Haymana is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Cem Haymana has authored 45 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Infectious Diseases and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Cem Haymana's work include Hormonal and reproductive studies (11 papers), COVID-19 Clinical Research Studies (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Cem Haymana is often cited by papers focused on Hormonal and reproductive studies (11 papers), COVID-19 Clinical Research Studies (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Cem Haymana collaborates with scholars based in Türkiye, Antigua and Barbuda and Cambodia. Cem Haymana's co-authors include Alper Sönmez, Serkan Tapan, Abdullah Taşlıpınar, İbrahim Demirci, Aydoğan Aydoğdu, İlker Taşçı, İlhan Satman, Teoman Doğru, Mahmut İlker Yılmaz and Mustafa Kutlu and has published in prestigious journals such as Diabetes, Atherosclerosis and Metabolism.

In The Last Decade

Cem Haymana

42 papers receiving 426 citations

Peers

Cem Haymana
J.P.H. van Wijk Netherlands
Anna R. Dover United Kingdom
Monia Elasmi Tunisia
Ahmed Amer Germany
Cem Haymana
Citations per year, relative to Cem Haymana Cem Haymana (= 1×) peers Mehmet Baştemir

Countries citing papers authored by Cem Haymana

Since Specialization
Citations

This map shows the geographic impact of Cem Haymana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cem Haymana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cem Haymana more than expected).

Fields of papers citing papers by Cem Haymana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cem Haymana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cem Haymana. The network helps show where Cem Haymana may publish in the future.

Co-authorship network of co-authors of Cem Haymana

This figure shows the co-authorship network connecting the top 25 collaborators of Cem Haymana. A scholar is included among the top collaborators of Cem Haymana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cem Haymana. Cem Haymana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Sönmez, Alper, İbrahim Demirci, Cem Haymana, et al.. (2023). Clinical characteristics of adult and paediatric patients with familial hypercholesterolemia: A real-life cross-sectional study from the Turkish National Database. Atherosclerosis. 375. 9–20. 3 indexed citations
6.
Atmaca, Ayşegül, İbrahim Demirci, Cem Haymana, et al.. (2021). No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study. Osteoporosis International. 33(1). 273–282. 10 indexed citations
7.
Haymana, Cem, İbrahim Demirci, İlker Taşçı, et al.. (2021). Clinical outcomes of non-diabetic COVID-19 patients with different blood glucose levels: a nationwide Turkish study (TurCoGlycemia). Endocrine. 73(2). 261–269. 5 indexed citations
8.
Emral, Rıfat, Cem Haymana, İbrahim Demirci, et al.. (2021). Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study. Diabetes Therapy. 12(11). 2857–2870. 13 indexed citations
9.
Bayram, Fahrı, Alper Sönmez, Cem Haymana, et al.. (2020). Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study). Lipids in Health and Disease. 19(1). 237–237. 8 indexed citations
10.
Haymana, Cem, Alper Sönmez, İbrahim Demirci, et al.. (2020). Patterns and preferences of antidiabetic drug use in Turkish patients with type 2 diabetes – A nationwide cross-sectional study (TEMD treatment study). Diabetes Research and Clinical Practice. 171. 108556–108556. 7 indexed citations
12.
Haymana, Cem, Alper Sönmez, Aydoğan Aydoğdu, et al.. (2017). Wpływ testosteronowej terapii zastępczej na stężenia witaminy D i FGF-23 w hipogonadyzmie wrodzonym. Endokrynologia Polska. 68(3). 311–616. 5 indexed citations
13.
Arslan, Mutluay, et al.. (2017). Association of neck circumference and pulmonary function in children. Annals of Allergy Asthma & Immunology. 119(1). 27–30. 4 indexed citations
14.
Haymana, Cem. (2017). Identifying Undiagnosed or Undertreated Patients with Familial Hypercholesterolemia from the Laboratory Records of a Tertiary Medical Center. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. 45(8). 731–738. 4 indexed citations
15.
Haymana, Cem, et al.. (2017). Assessment of a low ankle brachial index in young males with congenital hypogonadism. 1–1. 1 indexed citations
16.
Aydoğdu, Aydoğan, Cem Haymana, Onur Erdem, et al.. (2015). Trace Element Levels in Congenital Hypogonadotrophic Hypogonadism. Biological Trace Element Research. 171(1). 26–32. 2 indexed citations
17.
Sönmez, Alper, Cem Haymana, Erol Bolu, et al.. (2011). Metabolic syndrome and the effect of testosteron treatment in young men with congenital hypogonadotrophic hypogonadism. 26. 1 indexed citations
18.
Sönmez, Alper, Cem Haymana, Erol Bolu, et al.. (2011). Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism. European Journal of Endocrinology. 164(5). 759–764. 30 indexed citations
19.
Sönmez, Alper, Cem Haymana, Serkan Tapan, et al.. (2010). Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus. Endocrine. 37(3). 455–459. 29 indexed citations
20.
Erçin, Cemal Nuri, Teoman Doğru, Serkan Tapan, et al.. (2009). Levels of Soluble CD40 Ligand and P-Selectin in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences. 55(4). 1128–1134. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026